World Drug Safety Congress Americas 2020: my first virtual conference experience

World Drug Safety Congress Americas 2020: my first virtual conference experience

Last month I “virtually” attended the World Drug Safety Congress on September 2-3, 2020 on behalf of Adis Pharmacovigilance.   Originally scheduled as an in-person conference for March 24 – 25, 2020, due to COVID19, it was rescheduled as a virtual conference in September 2020. 

Continue reading “World Drug Safety Congress Americas 2020: my first virtual conference experience”

1998 Shirov: Bishop to h3! Dubbed an all-time strategic chess move… How do future pharmacovigilance strategies compare?

1998 Shirov: Bishop to h3! Dubbed an all-time strategic chess move… How do future pharmacovigilance strategies compare?

Report: Pharmacovigilance Strategy Meeting, Boston, MA, USA November 2017

In less time than it took for me to travel to the meeting from New Zealand – the day was over! Hard to believe that within a short eight hours, 25 lively roundtables were conducted, two keynote speeches were delivered, and the panel discussed the learning of the day, including challenges of monitoring diverse sources, importance of real-world evidence in the context of risk benefit, and the game-changing impact of artificial intelligence. Continue reading “1998 Shirov: Bishop to h3! Dubbed an all-time strategic chess move… How do future pharmacovigilance strategies compare?”